Quanterix Corp QTRX
News
Quanterix To Report Third Quarter 2026 Financial Results on November 9, 2026
Quanterix and Innovita Expand IVD Access in China with National Medical Products Administration Approvals
Quanterix Delivers on Spatial Biology Content Innovation Commitments at ESSB 2026
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Quanterix Names Dr. Yuri Fesko Chief Medical Officer